Koers EnteroMedics Inc Nasdaq
Aandelen
US29365M5058
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 9,99 mln. 9,29 mln. | Omzet 2025 * | 11,99 mln. 11,14 mln. | Marktkapitalisatie | 3,97 mln. 3,69 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -6 mln. -5,58 mln. | Nettowinst (verlies) 2025 * | -5 mln. -4,65 mln. | EV/omzet 2024 * | 0,4 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,33 x |
K/w-verhouding 2024 * |
-0,38
x | K/w-verhouding 2025 * |
-0,47
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,83% |
Recentste transcriptie over EnteroMedics Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Hickey
CEO | Chief Executive Officer | 59 | 01-02-20 |
Director of Finance/CFO | 63 | 15-06-21 | |
Dov Gal
CMP | Compliance Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gary Blackford
BRD | Director/Board Member | 66 | 01-01-16 |
Dan Gladney
CHM | Chairman | 70 | 01-11-15 |
Director/Board Member | 70 | 15-06-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,84% | 218 mld. | |
+7,35% | 184 mld. | |
+13,04% | 135 mld. | |
-1,33% | 62,38 mld. | |
+11,80% | 51,37 mld. | |
+4,81% | 50,9 mld. | |
+0,30% | 40,87 mld. | |
+2,78% | 36,28 mld. | |
+26,14% | 31,88 mld. |